株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

セルベースアッセイ & ハイコンテントスクリーニング (HCS) の世界市場:予測・分析

Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2020 to 2024

発行 Howe Sound Research 商品コード 854114
出版日 ページ情報 英文 235 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
セルベースアッセイ & ハイコンテントスクリーニング (HCS) の世界市場:予測・分析 Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2020 to 2024
出版日: 2019年11月02日 ページ情報: 英文 235 Pages
概要

当レポートでは、世界のセルベースアッセイ & ハイコンテントスクリーニング (HCS) 市場について調査し、技術、市場動向、発展動向、および主要企業の分析を提供しており、ユーザータイプ・製品クラス別の市場、地域・種類別の市場規模などをまとめています。

第1章 イントロダクションと市場定義

  • セルベースアッセイとは?
  • 治験の失敗
  • 市場定義
  • 調査手法
  • 米国の医療市場・医薬品研究費 - 展望

第2章 セルベースアッセイ:技術ガイド

  • 細胞培養
  • 細胞アッセイ
  • 細胞生存アッセイ
  • 細胞増殖アッセイ
  • 細胞毒性アッセイ
  • 細胞老化アッセイ
  • アポトーシス
  • オートファジー
  • 壊死
  • 酸化ストレス
  • 2D vs. 3D
  • シグナル伝達経路、GPCR
  • 免疫調製 & 阻害
  • レポーター遺伝子技術
  • CBA設計 & 開発
  • セルベースアッセイ:まとめ

第3章 産業概要

  • 市場参入企業

第4章 市場動向

  • 成長促進要因
  • 成長抑制要因
  • 技術開発

第5章 セルベースアッセイの近年の発展動向

  • 近年の発展動向

第6章 主なセルベースアッセイ企業のプロファイル

  • Abcam
  • Agilent
  • Beckman Coulter, Inc.
  • Becton Dickinson
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments
  • BioVision, Inc.
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories, Inc.
  • Cisbio Bioassays
  • Corning, Inc.
  • Cytovale
  • Enzo Life Sciences, Inc.
  • Eurofins DiscoverX Corporation
  • Evotec AG
  • Excellerate Bioscience
  • 富士フイルムセルラー・ダイナミクス・インターナショナル
  • GE Healthcare Life Sciences
  • Hemogenix
  • Horizon Discovery Group plc
  • Invivogen
  • Leica Biosystems
  • Lonza Group Ltd.
  • Merck KgaA
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • Ncardia
  • New England Biolabs, Inc.
  • オリンパス
  • Origene Technologies
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen NV
  • Reaction Biology
  • Roche Group
  • Sartorius
  • ソニーバイオテクノロジー
  • Stemcells Technologies Canada Inc.
  • Thermo Fisher Scientific, Inc.
  • TTP Labtech
  • Vitro Biopharma

第7章 世界市場の規模

  • 世界のセルベースアッセイ市場規模:地域別 (図表付き)
  • 世界のセルベースアッセイ市場規模:種類別 (図表付き)

第8章 世界市場:ユーザータイプ別

  • 医薬品市場
  • 基礎研究市場
  • 工業/化粧品市場

第9章 セルベースアッセイ:製品クラス別

  • 装置市場
  • 試薬市場
  • サービス市場
  • ソフトウェア市場

第10章 付録

図表

Table of Tables

  • Table 1 The Large Variety of Cell Lines
  • Table 2 Some Common Viability Assays
  • Table 3 Oxidative Stress Related Diseases
  • Table 4 Important Signalling Pathways
  • Table 5 Market Players by Type
  • Table 6 Five Factors Driving Growth
  • Table 7 Three Factors Limiting Growth
  • Table 8 Cell Based Assays Global Market by Region
  • Table 9 Cell Based Assays Global Market by User Type
  • Table 10 Pharmaceutical Market by Region
  • Table 11 Basic Research Market by Region
  • Table 12 Industrial/Cosmetic Market by Region
  • Table 13 Instrument Market by Region
  • Table 14 Reagent Market by Region
  • Table 15 Services Market by Region
  • TABLE 16 SOFTWARE MARKET BY REGION

Table of Figures

  • Figure 1 Reasons for clinical Failure by Phase
  • Figure 2 Immunotherapy Clinical Trial Growth
  • Figure 3 Pharmaceutical Research Expenditures 2001 to 2017 ($Billion)
  • Figure 4 Oxidative Stress and Free Radical Toxicity
  • Figure 5 FDA Cancer Drug Approvals
  • Figure 6 Growth rates of Cell Based Assays by Product Class
  • Figure 7 Market Size by Region
  • Figure 8 Global Market by Region
  • Figure 9 Chart of Global Market by User Type
  • Figure 10 Growth Rates of Industry Segments
  • Figure 11 Cell Based Assay Share Change by User Type
  • Figure 12 Chart - Pharmaceutical Market by Region
  • Figure 13 Chart - Basic Research Market by Region
  • Figure 14 Chart - Industrial/Cosmetic Market by Region
  • Figure 15 Chart - Instrument Market by Region
  • Figure 16 Chart - Reagent Market by Region
  • Figure 17 Chart -Services Market by Region
  • FIGURE 18 CHART -SOFTWARE MARKET BY REGION
  • Figure 19 FDA Cancer Drug Approvals by Year
  • Figure 20 Clinical Trials for Immunotherapy by Year
  • Figure 21 Share of Pharma R&D by Country
目次

OVERVIEW:

Cell Based Assays are a mainstay of drug development and scientific research, but growth is now accelerating as new immuno-oncology markets create unprecedented investment in the race to cure cancer. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1 What are Cell Based Assays?
  • 1.2 Clinical Trial Failures
    • 1.2.1 Immuno-oncology Plays a Leading Role in Cell Based Assays
  • 1.3 Market Definition
    • 1.3.1 Market Size
    • 1.3.2 Currency
    • 1.3.3 Years
  • 1.4 Methodology
    • 1.4.1 Authors
    • 1.4.2 Sources
  • 1.5 U.S. Medical Market and Pharmceutical Research Spending - Perspective
    • 1.5.1 U.S. Expenditures for Pharmaceutical Research

2. Cell Based Assays - Guide to Technology

  • 2.1 Cell Cultures
    • 2.1.1 Cell Lines
    • 2.1.2 Primary Cells
    • 2.1.3 Stem Cells
      • 2.1.3.1 iPSC's - The Special Case
  • 2.2 Cell Assays
  • 2.3 Cell Viability Assays
  • 2.3 Cell Proliferation Assays
  • 2.4 Cytotoxicity Assays
  • 2.5 Cell Senescence Assays
  • 2.6 Apoptosis
  • 2.7 Autophagy
  • 2.8 Necrosis
  • 2.9 Oxidative Stress
  • 2.10 2D vs. 3D
  • 2.11 Signalling Pathways, GPCR
  • 2.12 Immune Regulation & Inhibition
  • 2.13 Reporter Gene Technology
  • 2.14 CBA Design & Development
  • 2.15 Cell Based Assays - The Takeaway

3. Industry Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Contract Research Organization
    • 3.1.3 Genomic Instrumentation Supplier
    • 3.1.5 Cell Line and Reagent Supplier
    • 3.1.6 Pharmaceutical Company
    • 3.1.7 Audit Body
    • 3.1.8 Certification Body

4. Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Candidate Growth
    • 4.1.2 Immuno-oncology
    • 4.1.3 Genomic Blizzard
    • 4.1.4 Technology Convergence
    • 4.1.5 The Insurance Effect
  • 4.2 Factors Limiting Growth
    • 4.2.1 CBA Development Challenges
    • 4.2.2 Instrument Integration
    • 4.2.3 Protocols
  • 4.3 Technology Development
    • 4.3.1 3D Assays
    • 4.3.2 Automation
    • 4.3.3 Software
    • 4.3.4 Primary Cells
    • 4.3.5 Signalling and Reporter Genes
    • 4.3.6 The Next Five Years

5. Cell Based Assays Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
      • High-throughput Identifies cancer drug candidates
      • Velabs Therapeutics partners with Alytas Therapeutics to develop a
      • novel immune-based therapy for obesity
      • InSphero platform selected to test Cyclerion's sGC stimulator technology
      • OcellO to provide in vitro research services to Merus
      • Charles River Laboratories to acquire Citoxlab
      • Reaction Biology Corporation Purchases ProQinase GmbH
      • Cisbio extends its assay portfolio for immuno-oncology drug discovery
      • STEMCELL Technologies Launches Next-Generation Culture System
      • Abcam Acquires Calico Biolabs
      • Evotec announces achievement in Celgene alliance utilizing IPSC screening
      • Fujifilm Cellular Dynamics Inc. launches iCELL Microglia
      • Cisbio and Excellerate Bioscience partner
      • Agilent Acquires Luxcel Biosciences
      • Horizon Discovery extends CRISPR Screening Service to primary human T cells
      • BioIVT Acquires Biological Specialty Corporation
      • Miltenyi Biotec acquires microscopy specialist LaVision BioTec
      • BioIVT acquires Clinical Trials Laboratory Services
      • ACEA Biosciences to be Acquired by Agilent Technologies
      • Olympus announces new 3D Cell Analysis technology
      • Beckman Coulter Launches Flow Cytometry Software
      • Agilent Technologies Inc. and BioTek Instruments, Inc to Create
      • Integrated Metabolic Analysis and Imaging Platform
      • Molecular Devices launches new features for ImageXpress Pico
      • Automated Cell Imaging System
      • Ncardia Launches Custom CRISPR Gene-editing in iPSC-derived Cell
      • Lines with Horizon Discovery as Partner
      • MilliporeSigma to sell Flow Cytometry Unit
      • Charles River Laboratories purchases Nanion Syncropatch 384PE
      • Reaction Biology and Promega announce new NanoBRET Technology
      • Nanion Technologies and Ncardia to enhance Options for Cardiac Researchers
      • Citoxlab signs deal with Experimental Pharmacology and Oncology
      • Berlin-Buch GmbH (EPO)
      • Battery Ventures Acquires TTP Labtech Limited
      • BD Launches Cell Sorter to Enable Sorting of Rare Cell Types
      • Enzo Life Sciences Introduces Validated Antibodies for IHC
      • Sartorius launches new high throughput bioreactor system

6. Profiles of Key Cell Based Assay Companies

  • Abcam
  • Agilent
  • Beckman Coulter, Inc.
  • Becton Dickinson
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments
  • BioVision, Inc.
  • Cell Biolabs, Inc
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories, Inc.
  • Cisbio Bioassays
  • Corning, Inc
  • Cytovale
  • Enzo Life Sciences, Inc.
  • Eurofins DiscoverX Corporation
  • Evotec AG
  • Excellerate Bioscience
  • Fujifilm Cellular Dynamics International
  • GE Healthcare Life Sciences
  • Hemogenix
  • Horizon Discovery Group plc
  • Invivogen
  • Leica Biosystems
  • Lonza Group Ltd.
  • Merck KgaA
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • Ncardia
  • New England Biolabs, Inc
  • Olympus
  • Origene Technologies
  • PerkinElmer, Inc
  • Promega Corporation
  • Qiagen NV
  • Reaction Biology
  • Roche Group
  • Sartorius
  • Sony Biotechnology
  • Stemcells Technologies Canada Inc.
  • Thermo Fisher Scientific, Inc.
  • TTP Labtech
  • Vitro Biopharma

7. Global Market Size

  • 7.1 Cell Based Assay Global Market Size by Region with Charts
  • 7.2 Cell Based Assays Global Market Size by Type with Charts

8. Global Market by User Type

  • 8.1 Pharmaceutical Market
    • 8.1.1 Pharmaceutical Market by Region with Chart
  • 8.2 Basic Research Market
    • 8.2.1 Basic Research Market by Region with Chart
  • 8.3 Industrial/Cosmetic Market
    • 8.3.1 Industrial/Cosmetic Market by Region with Chart

9. Cell Based Assay by Product Class

  • 9.1 Instrument Market
    • 9.1.1 Instrument Market by Region with Chart
  • 9.2 Reagent Market
    • 9.2.1 Reagent Market by Region with Chart
  • 9.3 Services Market
    • 9.3.1 Services Market by Region with Chart
  • 9.4 Software Market
    • 9.4.1 Software Market by Region with Chart

10. Appendices

  • 10.1 FDA Cancer Drug Approvals by Year
  • 10.2 Clinical Trials Started 2010 to 2016
  • 10.3 Share of Pharma R&D by Country
Back to Top